![]() |
市場調查報告書
商品編碼
1755848
2032 年口含煙市場預測:按產品類型、強度、口味、分銷管道、人口統計、應用和地區進行的全球分析Snus Market Forecasts to 2032 - Global Analysis By Product Type (Loose Snus, Portion Snus, and Other Product Types), Strength, Flavor, Distribution Channel, Demographics, Application and By Geography |
根據 Stratistics MRC 的數據,全球口含煙市場預計在 2025 年達到 34.2 億美元,到 2032 年將達到 53.9 億美元,預測期內的複合年成長率為 6.7%。
鼻煙是一種傳統上在瑞典和挪威使用的濕潤無煙煙草產品。它被放置在上唇下方,無需吐出,使其成為一種隱藏的吸煙替代品。鼻煙有散裝或預先包裝的小袋裝兩種形式,無需燃燒即可釋放尼古丁。它通常帶有調味劑,既能吸引傳統用戶,也能吸引尋求煙草替代品的現代消費者。不同國家對口含煙的監管有所不同,但有些市場允許合法銷售。
根據挪威統計局發布的「菸草、酒精和其他藥物」數據,2021年,16至74歲人口中有15%的人報告每天使用口含煙,比2020年略有增加2個百分點。
無煙煙草產品需求不斷成長
人們對吸菸相關健康風險的認知不斷提高,推動了對無煙煙草替代品的需求。消費者對低風險產品的渴望,推動了全球口含煙市場的成長。公共場所吸煙限制進一步推動了無菸煙草的普及。此外,社會對適度菸草消費的接受度不斷提高,也推動了市場擴張。因此,製造商正致力於擴大產品供應,以滿足不斷變化的偏好。
與尼古丁袋裝電子煙和電子煙的競爭
由於尼古丁袋裝電子煙不含菸草成分且被認為健康風險較低,消費者擴大選擇尼古丁袋裝電子煙。電子煙產品憑藉其可自訂的口味和最新技術的融合,持續吸引著用戶。監管政策傾向於支持尼古丁替代品而非傳統菸草產品,這進一步影響了口含煙的銷售。此外,尼古丁袋裝電子煙和電子煙製造商的積極行銷宣傳活動也影響著消費者的選擇。這種競爭格局對尋求維持市場佔有率的口含煙製造商構成了挑戰。
轉向減害產品
各國政府和衛生組織正在推廣無煙煙草替代品,以最大限度地減少吸菸相關疾病的影響。研發投入的不斷增加,使得產品配方得到改進,健康風險也隨之降低。包括有機和無添加劑在內的創新鼻煙品種的推出,對注重健康的消費者頗具吸引力。對尼古丁成癮性較低的菸草產品的需求不斷成長,也推動了市場的成長。隨著人們對減少危害的日益關注,預計口含煙行業將受益於有利的消費趨勢。
健康問題和警告
警告標籤和公共衛生宣傳活動提高了人們的意識,卻阻礙了潛在消費者的消費,並限制了市場擴張。此外,尤其是在歐盟等地區,嚴格的行銷和包裝法規進一步限制了該行業的運作。口含煙作為危害較小的吸菸替代品的觀念也受到了質疑,新的研究對其安全性提出了質疑。所有這些因素都降低了消費者信心,對市場的成長潛力構成了重大挑戰。
COVID-19的影響
由於消費者購買行為的變化和供應鏈中斷,新冠疫情對口含煙市場產生了重大影響。封鎖和限制措施暫時減少了包括鼻煙在內的菸草製品的銷售量。然而,網路購物和電子商務的普及有助於維持市場需求。疫情提高了人們對呼吸健康的認知,導致一些使用者轉向無菸煙草替代品。疫情過後,製造商正致力於透過線上分銷管道提高可及性。
預計 Ruth 鼻煙將成為預測期內最大的
預計散裝鼻煙市場將在預測期內佔據最大市場佔有率,這得益於其在長期用戶中的傳統吸引力。散裝鼻煙允許使用者客製化份量,使其成為經驗豐富的消費者的首選。高品質、濃郁煙草口味的散裝鼻煙的供應進一步推動了市場需求。此外,某些地區對散裝鼻煙的文化偏好也促進了市場持續成長。
預計預測期內調味口含煙市場將以最高複合年成長率成長
預計在預測期內,調味口含煙細分市場將實現最高成長率。薄荷、莓果和柑橘類等口味的鼻煙品種對老用戶和新用戶都極具吸引力。越來越多的異國風味和創新配方正在吸引更年輕的消費群體。此外,無糖和天然成分調味口含煙產品的推出也正在擴大市場。
由於消費者意識的提升和菸草消費的成長,預計亞太地區將在預測期內佔據最大的市場佔有率。無煙煙草替代品的接受度不斷提高,尤其是在吸菸法規嚴格的國家,正在推動市場成長。可支配所得水準的提高和都市化正在影響購買模式。政府支持菸草減害策略的措施正在推動口含煙的普及。
由於消費行為健康意識的增強以及監管變化,預計北美將在預測期內實現最高的複合年成長率。低風險菸草產品的需求激增,推動了口含煙市場的擴張。消費者對減害策略的認知不斷提高,也推動了鼻煙的採用率。知名製造商對產品創新的投資也推動了鼻煙市場的成長。
According to Stratistics MRC, the Global Snus Market is accounted for $3.42 billion in 2025 and is expected to reach $5.39 billion by 2032 growing at a CAGR of 6.7% during the forecast period. Snus is a moist, smokeless tobacco product traditionally used in Sweden and Norway. It is placed under the upper lip and does not require spitting, making it a discreet alternative to smoking. Available in loose or portioned pouches, snus delivers nicotine without combustion. Often flavored, it appeals to both traditional users and modern consumers seeking tobacco alternatives. Snus is regulated differently across countries, with legal sales permitted in select markets.
According to data published by Statistics Norway on 'Tobacco, alcohol, and other drugs,' in 2021, 15 percent of individuals aged 16 to 74 reported using snus daily, marking a slight increase of 2 percentage points since 2020.
Increasing demand for smokeless tobacco products
The rising awareness about the health risks associated with smoking has led to an increasing demand for smokeless tobacco alternatives. Consumers are seeking reduced-risk products, contributing to the growth of snus in global markets. Regulatory restrictions on smoking in public places are further driving the adoption of smokeless tobacco. Additionally, growing social acceptance of discreet tobacco consumption is fueling market expansion. As a result, manufacturers are focusing on expanding their product offerings to meet evolving preferences.
Competition from nicotine pouches & vapes
Consumers are increasingly opting for nicotine pouches due to their tobacco-free composition and perceived lower health risks. Vaping products continue to attract users with customizable flavors and modern technology integration. Regulatory policies favoring nicotine alternatives over traditional tobacco products are further impacting snus sales. Additionally, aggressive marketing campaigns by nicotine pouch and vape manufacturers are influencing consumer choices. This competitive landscape presents challenges for snus manufacturers aiming to maintain market share.
Shift toward harm reduction products
Governments and health organizations are promoting smokeless tobacco alternatives to minimize the impact of smoking-related diseases. Increasing investment in research and development is leading to improved product formulations with reduced health risks. The introduction of innovative snus varieties, including organic and additive-free options, is appealing to health-conscious consumers. Rising demand for tobacco products with lower nicotine dependency is driving market growth. As the focus on harm reduction intensifies, the snus industry is expected to benefit from favorable consumer trends.
Health concerns & warnings
Warning labels and public health campaigns have raised awareness, deterring potential consumers and limiting market expansion. Additionally, stringent regulations on marketing and packaging, especially in regions like the EU, further constrain industry operations. The perception of snus as a less harmful alternative to smoking is also under scrutiny, as emerging studies challenge its safety. These factors collectively reduce consumer trust and pose major challenges to the market's growth potential.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the snus market due to changes in consumer purchasing behavior and supply chain disruptions. Lockdowns and restrictions led to a temporary decline in tobacco product sales, including snus. However, increased online shopping and e-commerce adoption helped sustain market demand. The pandemic heightened awareness of respiratory health, leading some users to shift toward smokeless tobacco alternatives. Post-pandemic, manufacturers are focusing on enhancing accessibility through online distribution channels.
The loose snus segment is expected to be the largest during the forecast period
The loose snus segment is expected to account for the largest market share during the forecast period, due to its traditional appeal among long-time users. Loose snus allows users to customize their portion size, making it a preferred choice for experienced consumers. The availability of high-quality variants with rich tobacco flavors is further driving market demand. Additionally, cultural preferences for loose snus in certain regions contribute to sustained growth.
The flavored snus segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the flavored snus segment is predicted to witness the highest growth rate, due to rising consumer preference for enhanced taste experiences. Flavored snus varieties, including mint, berry, and citrus, appeal to both seasoned and new users. The increasing availability of exotic flavors and innovative blends is attracting younger demographics. Additionally, the introduction of sugar-free and natural ingredient-based flavored snus products is expanding market reach.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising consumer awareness and expanding tobacco consumption. The growing acceptance of smokeless tobacco alternatives, particularly in countries with strict smoking regulations, is driving market growth. Increasing disposable income levels and urbanization are influencing purchasing patterns. Government initiatives supporting tobacco harm reduction strategies are promoting snus adoption.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to increasing health-conscious consumer behavior and regulatory shifts. The demand for reduced-risk tobacco products is growing rapidly, driving snus market expansion. Rising awareness regarding harm reduction strategies among consumers is boosting adoption rates. The presence of prominent manufacturers investing in product innovation is accelerating growth.
Key players in the market
Some of the key players profiled in the Snus Market include Swedish Match AB, British American Tobacco (BAT), Altria Group Inc., Philip Morris International (PMI), Imperial Brands plc, GN Tobacco Sweden AB, Japan Tobacco International (JTI), Skruf Snus AB, Another Snus Factory, Dholakia Tobacco Pvt. Ltd., Mac Baren Tobacco Company A/S, Ministry of Snus, Nordic Snus AB, Kurbits Snus AB, and Fiedler & Lundgren AB.
In September 2024, Philip Morris International Inc. announces the sale of its subsidiary Vectura Group Ltd. (Vectura) to Molex Asia Holdings Ltd., and the establishment of master service agreements to develop Vectura Fertin Pharma's inhaled therapeutics proprietary pipeline. Vectura will be operated by Phillips Medisize, a Molex company.
In March 2024, Altria Group, Inc. announced that it has agreed to sell 35 million shares of Anheuser-Busch InBev SA/NV through a global secondary offering (offering) comprised of a public offering of ABI ordinary shares represented by American depositary shares (ADS) in the United States, a public offering of ABI ordinary shares in the United States, a concurrent private placement of ABI ordinary shares in the European Economic Area.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.